Quarterly report pursuant to Section 13 or 15(d)

Non-Controlling Interests (Schedule of Non-Controlling Interests in Consolidated Entities) (Details)

v3.23.1
Non-Controlling Interests (Schedule of Non-Controlling Interests in Consolidated Entities) (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Noncontrolling Interest [Line Items]      
Net loss attributable to non-controlling interests $ (33,608) $ (33,718) $ (127,338)
Non-controlling interests in consolidated entities (17,990)   8,304
Urica      
Noncontrolling Interest [Line Items]      
Net loss attributable to non-controlling interests (470)   (1,251)
Non-controlling interests in consolidated entities $ (3,901)   $ (3,908)
Non-controlling ownership 34.50%   34.50%
Aevitas      
Noncontrolling Interest [Line Items]      
Net loss attributable to non-controlling interests $ (41)   $ (425)
Non-controlling interests in consolidated entities $ (5,891)   $ (5,753)
Non-controlling ownership 45.20%   45.90%
Avenue      
Noncontrolling Interest [Line Items]      
Net loss attributable to non-controlling interests $ (6,390)   $ (2,355)
Non-controlling interests in consolidated entities $ (1,629)   $ 3,054
Non-controlling ownership 87.80%   82.00%
Baergic      
Noncontrolling Interest [Line Items]      
Net loss attributable to non-controlling interests     $ (113)
Non-controlling ownership     39.00%
Cellvation      
Noncontrolling Interest [Line Items]      
Net loss attributable to non-controlling interests $ (26)   $ (102)
Non-controlling interests in consolidated entities $ (1,860)   $ (1,791)
Non-controlling ownership 21.30%   21.70%
Checkpoint      
Noncontrolling Interest [Line Items]      
Net loss attributable to non-controlling interests $ (8,425)   $ (48,406)
Non-controlling interests in consolidated entities $ (18,607)   $ (16,008)
Non-controlling ownership 83.90%   81.50%
Coronado SO      
Noncontrolling Interest [Line Items]      
Net loss attributable to non-controlling interests $ 0   $ 0
Non-controlling interests in consolidated entities $ (290)   $ (291)
Non-controlling ownership 13.00%   13.00%
Cyprium      
Noncontrolling Interest [Line Items]      
Net loss attributable to non-controlling interests $ (538)   $ (1,173)
Non-controlling interests in consolidated entities $ (4,392)   $ (3,817)
Non-controlling ownership 28.30%   29.80%
Helocyte      
Noncontrolling Interest [Line Items]      
Net loss attributable to non-controlling interests $ (16)   $ (122)
Non-controlling interests in consolidated entities $ (5,865)   $ (5,900)
Non-controlling ownership 17.50%   18.30%
JMC      
Noncontrolling Interest [Line Items]      
Net loss attributable to non-controlling interests $ (4,403)   $ (12,458)
Non-controlling interests in consolidated entities $ 3,302   $ 7,429
Non-controlling ownership 43.90%   41.60%
Mustang      
Noncontrolling Interest [Line Items]      
Net loss attributable to non-controlling interests $ (13,293)   $ (60,821)
Non-controlling interests in consolidated entities $ 23,564   $ 37,640
Non-controlling ownership 79.00%   82.70%
Oncogenuity      
Noncontrolling Interest [Line Items]      
Net loss attributable to non-controlling interests $ (6)   $ (111)
Non-controlling interests in consolidated entities $ (1,636)   $ (1,575)
Non-controlling ownership 27.40%   24.90%
Tamid      
Noncontrolling Interest [Line Items]      
Net loss attributable to non-controlling interests $ 0   $ (1)
Non-controlling interests in consolidated entities $ (785)   $ (776)
Non-controlling ownership 22.80%   22.80%